Biologics and Biosimilars as Treatment Options for Psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Huvudupphovsman: | Moya, Amena Khatun |
---|---|
Övriga upphovsmän: | Kabir, Dr. Eva Rahman |
Materialtyp: | Lärdomsprov |
Språk: | en_US |
Publicerad: |
Brac University
2023
|
Ämnen: | |
Länkar: | http://hdl.handle.net/10361/17712 |
Liknande verk
-
Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
av: Akter, Anika
Publicerad: (2022) -
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
av: Islam, Nahidul
Publicerad: (2023) -
Detection of skin diseases using deep learning
av: Shodoy, Masuk Ur Rahman
Publicerad: (2024) -
Biosimilar in lymphoma treatment
av: Tanisha, Mehrin Haque
Publicerad: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
av: Tabassum, Turana
Publicerad: (2022)